Insulin-Like Growth Factors in Normal and Diseased Kidney

Endocrinology and Metabolism Clinics of North America

Volumn 41, Issue 2, 2012, Pages 351-374

  Kiepe, Daniela ^a   Tönshoff, Burkhard ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

IGF system; Kidney disease; Pathophysiology; Treatment

Indexed keywords

PLACEBO; RECOMBINANT GROWTH HORMONE; RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN BINDING PROTEIN 6; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ACUTE KIDNEY FAILURE; ANATOMICAL VARIATION; BELL PALSY; CHRONIC KIDNEY FAILURE; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DRUG INTERMITTENT THERAPY; DRUG WITHDRAWAL; EMBRYO DEVELOPMENT; ENZYME ACTIVITY; ENZYME INHIBITION; GINGIVA HYPERTROPHY; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION; GROWTH HORMONE DEFICIENCY; GROWTH REGULATION; GROWTH RETARDATION; HORMONAL THERAPY; HUMAN; KIDNEY; KIDNEY BLOOD FLOW; KIDNEY DEVELOPMENT; KIDNEY DISEASE; KIDNEY TUBULE; MALNUTRITION; NEPHROTIC SYNDROME; NONHUMAN; PATHOPHYSIOLOGY; PERICARDITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIDE EFFECT; TACHYPHYLAXIS; TREATMENT OUTCOME;

ANIMALS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; KIDNEY; KIDNEY DISEASES; MICE; RATS; SOMATOMEDINS;

EID: 84861978293     PISSN: 08898529     EISSN: 15584410     Source Type: Journal    
DOI: 10.1016/j.ecl.2012.04.015     Document Type: Review

References (170)

1. Baxter R.C. Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities. Am J Physiol Endocrinol Metab 2000, 278:E967-E976.
2. Jones J.I., Clemmons D.R. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995, 16:3-34.
3. Schneider M.R., Wolf E., Hoeflich A., et al. IGF-binding protein-5: flexible player in the IGF system and effector on its own. J Endocrinol 2003, 172:423-440.
4. Parrizas M., Saltiel A.R., LeRoith D. Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3'-kinase and mitogen-activated protein kinase pathways. J Biol Chem 1997, 272:154-161.
5. Tsakiridis T., Tsiani E., Lekas P., et al. Insulin, insulin-like growth factor-I and platelet-derived growth factor activate extracellular signal-regulated kinase by distinct pathways in muscle cells. Biochem Biophys Res Commun 2001, 288:205-211.
6. Grey A., Chen Q., Xu X., et al. Parallel phosphatidylinositol-3 kinase and p42/44 mitogen-activated protein kinase signaling pathways subserve the mitogenic and antiapoptotic actions of insulin-like growth factor I in osteoblastic cells. Endocrinology 2003, 144:4886-4893.
7. Petley T., Graff K., Jiang W., et al. Variation among cell types in the signaling pathways by which IGF-I stimulates specific cellular responses. Horm Metab Res 1998, 31:70-76.
8. Rabkin R., Brody M., Lu L.H., et al. Expression of the genes encoding the rat renal insulin-like growth factor-I system. J Am Soc Nephrol 1995, 6:1511-1518.
9. Chin E., Bondy C. Insulin-like growth factor system gene expression in the human kidney. J Clin Endocrinol Metab 1992, 75:962-968.
10. Rabkin R. Insulin-like growth factor-I treatment of acute renal failure. J Lab Clin Med 1995, 125:684-685.
11. Flyvbjerg A. Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease. Diabetologia 2000, 43:1205-1223.
12. Flyvbjerg A. Potential use of growth hormone receptor antagonist in the treatment of diabetic kidney disease. Growth Horm IGF Res 2001, 11(Suppl A):S115-S119.
13. Rabkin R., Fervenza F.C. Renal hypertrophy and kidney disease in diabetes. Diabetes Metab Rev 1996, 12:217-241.
14. Tisher C., Madsen K. Anatomy of the kidney. The kidney 1985, 3-60. W.B. Saunders Co, Philadelphia. B. Brenner, F. Recotr (Eds.).
15. Osthanondh V., Potter E. Development of the human kidney as shown by microdissection. III. Formation and interrelationship of collecting tubules and nephrons. Arch Pathol 1963, 76:290.
16. Osthanondh V., Potter E. Development of the human kidney as shown by microdissection. II. Renal pelvis, calyces, and papillae. Arch Pathol 1963, 76:227.
17. Hammerman M.R., Ryan G., Miller S.B. Expression of insulin-like growth factor in adult and embryonic kidney. Miner Electrolyte Metab 1992, 18:253-255.
18. Rogers S.A., Ryan G., Hammerman M.R. Insulin-like growth factors I and II are produced in the metanephros and are required for growth and development in vitro. J Cell Biol 1991, 113:1447-1453.
19. Liu Z.Z., Kumar A., Wallner E.L., et al. Trophic effect of insulin-like growth factor-I on metanephric development: relationship to proteoglycans. Eur J Cell Biol 1994, 65:378-391.
20. Rogers S.A., Ryan G., Hammerman M.R. Metanephric transforming growth factor-α is required for renal organogenesis in vitro. Am J Physiol 1992, 262:F533-F539.
21. Hammerman M.R., Rogers S.A., Ryan G. Growth factors and kidney development. Pediatr Nephrol 1993, 7:616-620.
22. Kanwar Y.S., Liu Z.Z., Wada J. Insulin-like growth factor-I receptor in metanephric development. Contrib Nephrol 1994, 107:168-173.
23. Cascieri M.A., Chicchi G.G., Bayne M.L. Characterization of the biological activity of IGF-I analogs with reduced affinity for IGF receptors and binding proteins. Adv Exp Med Biol 1991, 293:23-30.
24. Mathews L.S., Hammer R.E., Behringer R.R., et al. Growth enhancement of transgenic mice expressing human insulin-like growth factor I. Endocrinology 1988, 123:2827-2833.
25. Quaife C.J., Mathews L.S., Pinkert C.A., et al. Histopathology associated with elevated levels of growth hormone and insulin-like growth factor I in transgenic mice. Endocrinology 1989, 124:40-48.
26. Doi T., Striker L.J., Gibson C.C., et al. Glomerular lesions in mice transgenic for growth hormone and insulin-like growth factor-I. I. Relationship between increased glomerular size and mesangial sclerosis. Am J Pathol 1990, 137:541-552.
27. Guler H.P., Zapf J., Scheiwiller E., et al. Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomised rats. Proc Natl Acad Sci U S A 1988, 85:4889-4893.
28. Rogers S.A., Powell-Braxton L., Hammerman M.R. Insulin-like growth factor I regulates renal development in rodents. Dev Genet 1999, 24:293-298.
29. Sjogren K., Liu J.L., Blad K., et al. Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc Natl Acad Sci U S A 1999, 96:7088-7092.
30. Svensson J., Tivesten A., Sjogren K., et al. Liver-derived IGF-I regulates kidney size, sodium reabsorption, and renal IGF-II expression. J Endocrinol 2007, 193:359-366.
31. Wallenius K., Sjogren K., Peng X.D., et al. Liver-derived IGF-I regulates GH secretion at the pituitary level in mice. Endocrinology 2001, 142:4762-4770.
32. Wolf E., Kramer R., Blum W.F., et al. Consequences of postnatally elevated insulin-like growth factor-II in transgenic mice: endocrine changes and effects on body and organ growth. Endocrinology 1994, 135:1877-1886.
33. Blackburn A., Schmitt A., Schmidt P., et al. Actions and interactions of growth hormone and insulin-like growth factor-II: body and organ growth of transgenic mice. Transgenic Res 1997, 6:213-222.
34. Moerth C., Schneider M.R., Renner-Mueller I., et al. Postnatally elevated levels of insulin-like growth factor-II (IGF-II) fail to rescue the dwarfism of IGF-I deficient mice except kidney weight. Endocrinology 2007, 148:441-451.
35. Matsell D.G., Delhanty P.J., Stepaniuk O., et al. Expression of insulin-like growth factor and binding protein genes during nephrogenesis. Kidney Int 1994, 46:1031-1042.
36. O'Mahoney J., Brandon M.R., Adams T.E. Development and tissue-specific regulation of ovine insulin-like growth factor II (IGF-II) mRNA expression. Mol Cell Endocrinol 1991, 78:87-96.
37. Liu Z.Z., Wada J., Alvares K., et al. Distribution and relevance of insulin-like growth factor-I receptor in metanephric development. Kidney Int 1993, 44:1242-1250.
38. Wada J., Liu Z.Z., Alvares K., et al. Cloning of cDNA for the alpha subunit of mouse insulin-like growth factor I receptor and the role of the receptor in metanephric development. Proc Natl Acad Sci U S A 1993, 90:10360-10364.
39. Delhanty P.J., Hill D.J., Shimasaki S., et al. Insulin-like growth factor binding protein-4, -5 and -6 mRNAs in the human fetus: localization to sites of growth and differentiation?. Growth Regul 1993, 3:8-11.
40. Delhanty P.J., Han V.K. The expression of insulin-like growth factor (IGF)-binding protein-2 and IGF-II genes in the tissues of the developing ovine fetus. Endocrinology 1993, 132:41-52.
41. Rajkumar K., Barron D., Lewitt M.S., et al. Growth retardation and hyperglycemia in insulin-like growth factor binding protein-1 transgenic mice. Endocrinology 1995, 136:4029-4034.
42. Doublier S., Amri K., Seurin D., et al. Overexpression of human insulin-like growth factor binding protein-1 in the mouse leads to nephron deficit. Pediatr Res 2001, 49:660-666.
43. Doublier S., Seurin D., Fouqueray B., et al. Glomerulosclerosis in mice transgenic for human insulin-like growth factor-binding protein-1. Kidney Int 2000, 57:2299-2307.
44. Hoeflich A., Nedbal S., Blum W.F., et al. Growth inhibition in giant growth hormone transgenic mice by overexpression of insulin-like growth factor-binding protein-2. Endocrinology 2001, 142:1889-1898.
45. Modric T., Silha J.V., Shi Z., et al. Phenotypic manifestations of insulin-like growth factor-binding protein-3 overexpression in transgenic mice. Endocrinology 2001, 142:1958-1967.
46. Murphy L.J., Molnar P., Lu X., et al. Expression of human insulin-like growth factor-binding protein-3 in transgenic mice. J Mol Endocrinol 1995, 15:293-303.
47. Bienvenu G., Seurin D., Grellier P., et al. Insulin-like growth factor binding protein-6 transgenic mice: postnatal growth, brain development, and reproduction abnormalities. Endocrinology 2004, 145:2412-2420.
48. Salih D.A., Tripathi G., Holding C., et al. Insulin-like growth factor-binding protein 5 (Igfbp5) compromises survival, growth, muscle development, and fertility in mice. Proc Natl Acad Sci U S A 2004, 101:4314-4319.
49. Schimpff R.M., Donnadieu M., Duval M. Serum somatomedin activity measured as sulphation factor in peripheral, hepatic and renal veins of mongrel dogs: basal levels. Acta Endocrinol (Copenh) 1980, 93:67-72.
50. Mathews L.S., Norstedt G., Palmiter R.D. Regulation of insulin-like growth factor I gene expression by growth hormone. Proc Natl Acad Sci U S A 1986, 83:9343-9347.
51. Fujinaka H., Katsuyama K., Yamamoto K., et al. Expression and localization of insulin-like growth factor binding proteins in normal and proteinuric kidney glomeruli. Nephrology (Carlton) 2010, 15:700-709.
52. Bondy C.A., Chin E., Zhou J. Significant species differences in local IGF-I and -II gene expression. Adv Exp Med Biol 1993, 343:73-77.
53. Chin E., Michels K., Bondy C.A. Partition of insulin-like growth factor (IGF)-binding sites between the IGF-I and IGF-II receptors and IGF-binding proteins in the human kidney. J Clin Endocrinol Metab 1994, 78:156-164.
54. Andersson G., Jennische E. IGF-I immunoreactivity is expressed by regenerating renal tubular cells after ischaemic injury in the rat. Acta Physiol Scand 1988, 132:453-457.
55. Matejka G.L., Jennische E. IGF-I binding and IGF-I mRNA expression in the post-ischemic regenerating rat kidney. Kidney Int 1992, 42:1113-1123.
56. Kobayashi S., Clemmons D.R., Venkatachalam M.A. Colocalization of insulin-like growth factor-binding protein with insulin-like growth factor I. Am J Physiol 1991, 261:F22-F28.
57. Hise M.K., Mantzouris N.M., Lahn J.S., et al. Low-protein diet regulates a proximal nephron insulin-like growth factor binding protein. Am J Kidney Dis 1994, 23:849-855.
58. Chin E., Zhou J., Bondy C.A. Renal growth hormone receptor gene expression: relationship to renal insulin-like growth factor system. Endocrinology 1992, 131:3061-3066.
59. Chin E., Zhou J., Bondy C.A. Anatomical relationships in the patterns of insulin-like growth factor (IGF)-I, IGF binding protein-1, and IGF-I receptor gene expression in the rat kidney. Endocrinology 1992, 130:3237-3245.
60. Evan A.P., Henry D.P., Connors B.A., et al. Analysis of insulin-like growth factors (IGF)-I, and -II, type II IGF receptor and IGF-binding protein-2 mRNA and peptide levels in normal and nephrectomised rat kidney. Kidney Int 1995, 48:1517-1529.
61. Rabkin R., Haussman M. Renal metabolism of hormones. Principles and practice of endocrinology and metabolism 2000, 1895-1901. Lippincott, Philadelphia. K.L. Becker (Ed.).
62. Zumkeller W., Hall K. Immunoreactive insulin-like growth factor II in urine. Acta Endocrinol (Copenh) 1990, 123:499-503.
63. Gargosky S.E., Hasegawa T., Tapanainen P., et al. Urinary insulin-like growth factors (IGF) and IGF-binding proteins in normal subjects, growth hormone deficiency, and renal disease. J Clin Endocrinol Metab 1993, 76:1631-1637.
64. Flyvbjerg A., Nielsen S., Sheikh M.I., et al. Luminal and basolateral uptake and receptor binding of IGF-I in rabbit renal proximal tubules. Am J Physiol 1993, 265:F624-F633.
65. Li W., Fawcett J., Widmer H.R., et al. Nuclear transport of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in opossum kidney cells. Endocrinology 1997, 138:1763-1766.
66. Hasegawa Y., Cohen P., Yorgin P., et al. Characterization of urinary insulin-like growth factor binding proteins. J Clin Endocrinol Metab 1992, 74:830-835.
67. Garin E., Grant M., Silverstein J. Insulin-like growth factors in patients with active nephrotic syndrome. Am J Dis Child 1989, 143:865-867.
68. Hirschberg R., Kopple J.D. Evidence that insulin-like growth factor I increases renal plasma flow and glomerular filtration rate in fasted rats. J Clin Invest 1989, 83:326-330.
69. Baumann U., Eisenhauer T., Hartmann H. Increase of glomerular filtration rate and renal plasma flow by insulin-like growth factor-I during euglycaemic clamping in anaesthetized rats. Eur J Clin Invest 1992, 22:204-209.
70. Hirschberg R., Brunori G., Kopple J.D., et al. Effects of insulin-like growth factor I on renal function in normal men. Kidney Int 1993, 43:387-397.
71. Guler H.P., Eckardt K.U., Zapf J., et al. Insulin-like growth factor I increases glomerular filtration rate and renal plasma flow in man. Acta Endocrinol (Copenh) 1989, 121:101-106.
72. Hirschberg R., Kopple J.D., Blantz R.C., et al. Effects of recombinant human insulin-like growth factor I on glomerular dynamics in the rat. J Clin Invest 1991, 87:1200-1206.
73. Haylor J., Singh I., el Nahas A.M. Nitric oxide synthesis inhibitor prevents vasodilatation by insulin-like growth factor I. Kidney Int 1991, 39:333-335.
74. Tsukahara H., Gordienko D.V., Tönshoff B., et al. Direct demonstration of insulin-like growth factor-I-induced nitric oxide production by endothelial cells. Kidney Int 1994, 45:598-604.
75. Tönshoff B., Kaskel F.J., Moore L.C. Effects of insulin-like growth factor I on the renal juxtamedullary microvasculature. Am J Physiol 1998, 274:F120-F128.
76. Hirschberg R. Die aminosäure- und hormoninduzierte Modulation der Nierenfunktion und ihre mögliche Bedeutung für die Progression der chronischen Niereninsuffizienz 1988, Free University of Berlin, Berlin.
77. Feld S., Hirschberg R. Growth hormone, the insulin-like growth factor system, and the kidney. Endocr Rev 1996, 17:423-480.
78. Hirschberg R. Effects of growth hormone and IGF-I on glomerular ultrafiltration in growth hormone-deficient rats. Regul Pept 1993, 48:241-250.
79. Laron Z., Klinger B. IGF-I treatment of adult patients with Laron syndrome: preliminary results. Clin Endocrinol (Oxf) 1994, 41:631-638.
80. Giordano M., DeFronzo R.A. Acute effect of human recombinant insulin-like growth factor I on renal function in humans. Nephron 1995, 71:10-15.
81. Corvilain J., Abramow M., Bergans A. Some effects of human growth hormone on renal hemodynamics and on tubular phosphate transport in man. J Clin Invest 1962, 41:1230-1235.
82. Mulroney S.E., Lumpkin M.D., Haramati A. Antagonist to GH-releasing factor inhibits growth and renal Pi reabsorption in immature rats. Am J Physiol 1989, 257:F29-F34.
83. Hirschberg R. IGF-I is ultrafiltered into the urinary space and may exert biological effects in proximal tubules in the nephrotic syndrome. J Am Soc Nephrol 1993, 4:771. [abstract].
84. van Renen M.J., Hogg R.J., Sweeney A.L., et al. Accelerated growth in short children with chronic renal failure treated with both strict dietary therapy and recombinant growth hormone. Pediatr Nephrol 1992, 6:451-458.
85. Quigley R., Baum M. Effects of growth hormone and insulin-like growth factor I on rabbit proximal convoluted tubule transport. J Clin Invest 1991, 88:368-374.
86. Caverzasio J., Bonjour J.P. IGF-1 and phosphate homeostasis during growth. Nephrologie 1992, 13:109-113.
87. Caverzasio J., Bonjour J.P. Growth factors and renal regulation of phosphate transport. Pediatr Nephrol 1993, 7:802-806.
88. Ernest S., Coureau C., Escoubet B. Deprivation of phosphate increases IGF-II mRNA in MDCK cells but IGFs are not involved in phosphate transport adaptation to phosphate deprivation. J Endocrinol 1995, 145:325-331.
89. Bengtsson B.A., Edén S., Lönn L., et al. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab 1993, 76:309-317.
90. Jabri N., Schalch D.S., Schwartz S.L., et al. Adverse effects of recombinant human insulin-like growth factor I in obese insulin-resistant type II diabetic patients. Diabetes 1994, 43:369-374.
91. Clemmons D.R. Use of growth hormone and insulin-like growth factor I in catabolism that is induced by negative energy balance. Horm Res 1993, 40:62-67.
92. Beck J.C., McGarry E.E., Dyrenfurth I., et al. The metabolic effects of human and monkey growth hormone in man. Ann Intern Med 1958, 49:1090-1105.
93. Brenner B., Meyer T., Hostetter T. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 1982, 307:652-659.
94. Gallego M., Chai Q., Marrero M., et al. Stimulation of Na channels by IGF-I in A6 cells. Possible role of tyrosine phosphorylation. J Am Soc Nephrol 1995, 6:337. [abstract].
95. Moller S., Juul A., Becker U., et al. Concentrations, release, and disposal of insulin-like growth factor (IGF)-binding proteins (IGFBP), IGF-I, and growth hormone in different vascular beds in patients with cirrhosis. J Clin Endocrinol Metab 1995, 80:1148-1157.
96. Doi T., Striker L.J., Quaife C., et al. Progressive glomerulosclerosis develops in transgenic mice chronically expressing growth hormone and growth hormone releasing factor but not in those expressing insulinlike growth factor-1. Am J Pathol 1988, 131:398-403.
97. Ritz E., Tönshoff B., Worgall S., et al. Influence of growth hormone and insulin-like growth factor-I on kidney function and kidney growth. Pediatr Nephrol 1991, 5:509-512.
98. Mehls O., Irzynjec T., Ritz E., et al. Effects of rhGH and rhIGF-1 on renal growth and morphology. Kidney Int 1993, 44:1251-1258.
99. Pesce C.M., Striker L.J., Peten E., et al. Glomerulosclerosis at both early and late stages is associated with increased cell turnover in mice transgenic for growth hormone. Lab Invest 1991, 65:601-605.
100. Stiles A.D., Sosenko I.R., D'Ercole A.J., et al. Relation of kidney tissue somatomedin-C/insulin-like growth factor I to postnephrectomy renal growth in the rat. Endocrinology 1985, 117:2397-2401.
101. Flyvbjerg A., Orskov H., Nyborg K., et al. Kidney IGF-I accumulation occurs in four different conditions with rapid initial kidney growth in rats. Modern concepts of insulin-like growth factors 1991, 207-217. Elsevier: Science Publishing Co, New York. E.M. Spencer (Ed.).
102. Lajara R., Rotwein P., Bortz J.D., et al. Dual regulation of insulin-like growth factor I expression during renal hypertrophy. Am J Physiol 1989, 257:F252-F261.
103. Fagin J.A., Melmed S. Relative increase in insulin-like growth factor I messenger ribonucleic acid levels in compensatory renal hypertrophy. Endocrinology 1987, 120:718-724.
104. Hise M.K., Lahn J.S., Shao Z.M., et al. Insulin-like growth factor-I receptor and binding proteins in rat kidney after nephron loss. J Am Soc Nephrol 1993, 4:62-68.
105. Hise M.K., Li L., Mantzouris N., et al. Differential mRNA expression of insulin-like growth factor system during renal injury and hypertrophy. Am J Physiol 1995, 269:F817-F824.
106. Fervenza F.C., Tsao T., Hsu F., et al. Intrarenal insulin-like growth factor-1 axis after unilateral nephrectomy in rat. J Am Soc Nephrol 1999, 10(1):43-50.
107. Haylor J., Hickling H., El Eter E., et al. JB3, an IGF-I receptor antagonist, inhibits early renal growth in diabetic and uninephrectomized rats. J Am Soc Nephrol 2000, 11:2027-2035.
108. Haylor J.L., McKillop I.H., Oldroyd S.D., et al. IGF-I inhibitors reduce compensatory hyperfiltration in the isolated rat kidney following unilateral nephrectomy. Nephrol Dial Transplant 2000, 15:87-92.
109. Haramati A., Lumpkin M.D., Mulroney S.E. Early increase in pulsatile growth hormone release after unilateral nephrectomy in adult rats. Am J Physiol 1994, 266:F628-F632.
110. Phan V., Brophy P.D., Fleming G.M. Acute renal failure. Comprehensive pediatric nephrology 2008, 607-609. Elsevier, Philadelphia. D.F. Geary, F. Schaefer (Eds.).
111. Ding H., Qing P.Y., Gao X.L., et al. Time dependent changes in the expression of insulin-like growth factor I (IGF-I) and IGF-I receptor (IGF-I R) in tissue of rats with acute renal failure (ARF). J Am Soc Nephrol 1995, 6:461. [abstract].
112. Tsao T., Wang J., Fervenza F.C., et al. Renal growth hormone-insulin-like growth factor-I system in acute renal failure. Kidney Int 1995, 47:1658-1668.
113. Hirschberg R., Kopple J., Lipsett P., et al. Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure. Kidney Int 1999, 55:2423-2432.
114. Clark R., Mortensen D., Rabkin R. Recovery from acute ischaemic renal failure is accelerated by des-(1-3)-insulin-like growth factor-I. Clin Sci 1994, 86:709-714.
115. Ding H., Kopple J.D., Cohen A., et al. Recombinant human insulin-like growth factor-I accelerates recovery and reduces catabolism in rats with ischemic acute renal failure. J Clin Invest 1993, 91:2281-2287.
116. Miller S.B., Martin D.R., Kissane J., et al. Insulin-like growth factor I accelerates recovery from ischemic acute tubular necrosis in the rat. Proc Natl Acad Sci U S A 1992, 89:11876-11880.
117. Noguchi S., Kashihara Y., Ikegami Y., et al. Insulin-like growth factor-I ameliorates transient ischemia-induced acute renal failure in rats. J Pharmacol Exp Ther 1993, 267:919-926.
118. Franklin S.C., Moulton M., Sicard G.A., et al. Insulin-like growth factor I preserves renal function postoperatively. Am J Physiol 1997, 272:F257-F259.
119. Samaan N.A., Freeman R.M. Growth hormone levels in severe renal failure. Metabolism 1970, 19:102-113.
120. Pimstone B.L., Le Roith D., Epstein S., et al. Disappearance rates of serum growth hormone after intravenous somatostatin in renal and liver disease. J Clin Endocrinol Metab 1975, 41:392-395.
121. Davidson M., Fisher M., Dabir-Vaziri N., et al. Effect of protein intake and dialysis on the abnormal growth hormone, glucose, and insulin homeostasis in uremia. Metabolism 1976, 25:455-464.
122. Tönshoff B., Powell D.R., Zhao D., et al. Decreased hepatic insulin-like growth factor (IGF)-I and increased IGF binding protein-1 and -2 gene expression in experimental uremia. Endocrinology 1997, 138:938-946.
123. Chan W., Valerie K.C., Chan J.C.M. Expression of insulin-like growth factor-1 in uremic rats: growth hormone resistance and nutritional intake. Kidney Int 1993, 43:790-795.
124. Tönshoff B., Eden S., Weiser E., et al. Reduced hepatic growth hormone (GH) receptor gene expression and increased plasma GH binding protein in experimental uremia. Kidney Int 1994, 45:1085-1092.
125. Schaefer F., Chen Y., Tsao T., et al. Impaired JAK-STAT signal transduction contributes to growth hormone resistance in chronic uremia. J Clin Invest 2001, 108:467-475.
126. Phillips L.S., Fusco A.C., Unterman T.G., et al. Somatomedin inhibitor in uremia. J Clin Endocrinol Metab 1984, 59:764-772.
127. Blum W.F., Ranke M.B., Kietzmann K., et al. Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uraemia. Pediatr Nephrol 1991, 5:539-544.
128. Frystyk J., Ivarsen P., Skjaerbaek C., et al. Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure. Kidney Int 1999, 56:2076-2084.
129. Tönshoff B., Blum W.F., Wingen A.M., et al. Serum insulin-like growth factors (IGFs) and IGF binding proteins 1, 2, and 3 in children with chronic renal failure: relationship to height and glomerular filtration rate. J Clin Endocrinol Metab 1995, 80:2684-2691.
130. Ulinski T., Mohan S., Kiepe D., et al. Serum insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5 in children with chronic renal failure: relationship to growth and glomerular filtration rate. Pediatr Nephrol 2000, 14:589-597.
131. Holly J.M., Claffey D.C., Cwyfan-Hughes S.C., et al. Proteases acting on IGFBPs: their occurrence and physiological significance. Growth Regul 1993, 3:88-91.
132. Lee D.Y., Park S.K., Yorgin P.D., et al. Alteration in insulin-like growth factor-binding proteins (IGFBPs) and IGFBP-3 protease activity in serum and urine from acute and chronic renal failure. J Clin Endocrinol Metab 1994, 79:1376-1382.
133. Kiepe D., Ulinski T., Powell D.R., et al. Differential effects of IGFBP-1, -2, -3, and -6 on cultured growth plate chondrocytes. Kidney Int 2002, 62:1591-1600.
134. Kiepe D., Andress D.L., Mohan S., et al. Intact IGF-binding protein-4 and -5 and their respective fragments isolated from chronic renal failure serum differentially modulate IGF-I actions in cultured growth plate chondrocytes. J Am Soc Nephrol 2001, 12:2400-2410.
135. Gbadegesin R., Smoyer W. Nephrotic syndrome. Comprehensive pediatric nephrology 2008, 205-212. Elsevier, Philadelphia. D.F. Geary, F. Schaefer (Eds.).
136. Haffner D., Tönshoff B., Blum W.F., et al. Insulin-like growth factors (IGFs) and IGF binding proteins, serum acid-labile subunit and growth hormone binding protein in nephrotic children. Kidney Int 1997, 52:802-810.
137. Hirschberg R., Kaysen G.A. Insulin-like growth factor I and its binding proteins in the experimental nephritic syndrome. Endocrinology 1995, 136:1565-1571.
138. Flyvbjerg A., Landau D., Domene H., et al. The role of growth hormone, insulin-like growth factors (IGFs), and IGF-binding proteins in experimental diabetic kidney disease. Metabolism 1995, 44:67-71.
139. Flyvbjerg A., Bornfeldt K.E., Marshall S.M., et al. Kidney IGF-I mRNA in initial renal hypertrophy in experimental diabetes in rats. Diabetologia 1990, 33:334-338.
140. Flyvbjerg A., Frystyk J., Osterby R., et al. Kidney IGF-1 and renal hypertrophy in GH deficient dwarf rats. Am J Physiol 1992, 262:E956-E962.
141. Werner H., Shen-Orr Z., Stannard B., et al. Experimental diabetes increases insulin-like growth factor I and II receptor concentration and gene expression in kidney. Diabetes 1990, 39:1490-1497.
142. Landau D., Chin E., Bondy C., et al. Expression of insulin-like growth factor binding proteins in the rat kidney: effects of long-term diabetes. Endocrinology 1995, 136:1835-1842.
143. Baelde H.J., Eikmans M., Doran P.P., et al. Gene expression profiling in glomeruli from human kidneys with diabetic nephropathy. Am J Kidney Dis 2004, 43:636-650.
144. Spagnoli A., Chiarelli F., Vorwerk P., et al. Evaluation of the components of insulin-like growth factor (IGF)-IGF binding protein (IGFBP) system in adolescents with type 1 diabetes and persistent microalbuminuria: relationship with increased urinary excretion of IGFBP-3 18 kD N-terminal fragment. Clin Endocrinol (Oxf) 1999, 51:587-596.
145. Shinada M., Akdeniz A., Panagiotopoulos S., et al. Proteolysis of insulin-like growth factor-binding protein-3 is increased in urine from patients with diabetic nephropathy. J Clin Endocrinol Metab 2000, 85:1163-1169.
146. Fine R.N., Kohaut E., Brown D., et al. Long-term treatment of growth retarded children with chronic renal insufficiency, with recombinant human growth hormone. Kidney Int 1996, 49:781-785.
147. Haffner D., Wühl E., Schaefer F., et al. Factors predictive of the short- and long-term efficacy of growth hormone treatment in prepubertal children with chronic renal failure. The German Study Group for Growth Hormone Treatment in Chronic Renal Failure. J Am Soc Nephrol 1998, 9:1899-1907.
148. Hokken-Koelega A., Mulder P., De Jong R., et al. Long-term effects of growth hormone treatment on growth and puberty in patients with chronic renal insufficiency. Pediatr Nephrol 2000, 14:701-706.
149. Powell D.R., Liu F., Baker B.K., et al. Modulation of growth factors by growth hormone in children with chronic renal failure. The Southwest Pediatric Nephrology Study Group. Kidney Int 1997, 51:1970-1979.
150. Tönshoff B., Mehls O., Heinrich U., et al. Growth-stimulating effects of recombinant human growth hormone in children with end-stage renal disease. J Pediatr 1990, 4:561-566.
151. Hokken-Koelega A.C., Stijnen T., de Muinck Keizer-Schrama S.M., et al. Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure. Lancet 1991, 338:585-590.
152. Powell D.R., Durham S.K., Liu F., et al. The insulin-like growth factor axis and growth in children with chronic renal failure: a report of the Southwest Pediatric Nephrology Study Group. J Clin Endocrinol Metab 1998, 83:1654-1661.
153. Chernausek S.D., Backeljauw P.F., Frane J., et al. GH Insensitivity Syndrome Collaborative Group. Long-term treatment with recombinant insulin-like growth factor (IGF)-I in children with severe IGF-I deficiency due to growth hormone insensitivity. J Clin Endocrinol Metab 2007, 92:902-910.
154. Tönshoff B., Kiepe D., Ciarmatori S. Growth hormone/insulin-like growth factor system in children with chronic renal failure. Pediatr Nephrol 2005, 20:279-289.
155. Kovács G.T., Oh J., Kovács J., et al. Growth promoting effects of growth hormone and IGF-I are additive in experimental uremia. Kidney Int 1996, 49:1413-1421.
156. Edmondson S.R., Baker N.L., Oh J., et al. Growth hormone receptor abundance in tibial growth plates of uremic rats: GH/IGF-I treatment. Kidney Int 2000, 58:62-70.
157. Horber F.F., Haymond M.W. Human growth hormone prevents the protein catabolic side effects of prednisone in humans. J Clin Invest 1990, 86:265-272.
158. Jacob R., Barrett E., Plewe G., et al. Acute effects of insulin-like growth factor I on glucose and amino acid metabolism in the awake fasted rat. Comparison with insulin. J Clin Invest 1989, 83:1717-1723.
159. Guebre-Egziabher F., Juillard L., Boirie Y., et al. Short-term administration of a combination of recombinant growth hormone and insulin-like growth factor-I induces anabolism in maintenance hemodialysis. J Clin Endocrinol Metab 2009, 94:2299-2305.
160. Ike J.O., Fervenza F.C., Hoffman A.R., et al. Early experience with extended use of insulin-like growth factor-1 in advanced chronic renal failure. Kidney Int 1997, 51:840-849.
161. Miller S.B., Moulton M., O'Shea M., et al. Effects of IGF-I on renal function in end-stage chronic renal failure. Kidney Int 1994, 46:201-207.
162. Chan J.M., Stampfer M.J., Giovannucci E., et al. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 1998, 279:563-566.
163. Kuan Y., Surman J., Frystyk J., et al. Lack of effect of IGF-I on the glomerular filtration rate in non-diabetic patients with advanced chronic kidney disease. Growth Horm IGF Res 2009, 19:219-225.
164. Kiepe D., Van Der Pas A., Ciarmatori S., et al. Defined carboxy-terminal fragments of insulin-like growth factor (IGF) binding protein-2 exert similar mitogenic activity on cultured rat growth plate chondrocytes as IGF-I. Endocrinology 2008, 149:4901-4911.
165. Powell D.R., Liu F., Baker B., et al. Characterization of insulin-like growth factor binding protein-3 in chronic renal failure serum. Pediatr Res 1993, 33:136-143.
166. Durham S.K., Mohan S., Liu F., et al. Bioactivity of a 29-kilodalton insulin-like growth factor binding protein-3 fragment present in excess in chronic renal failure serum. Pediatr Res 1997, 42:335-341.
167. Powell D.R., Durham S.K., Brewer E.D., et al. Effects of chronic renal failure and growth hormone on serum levels of insulin-like growth factor-binding protein-4 (IGFBP-4) and IGFBP-5 in children: a report of the Southwest Pediatric Nephrology Study Group. J Clin Endocrinol Metab 1999, 84:596-601.
168. Ständker L., Braulke T., Mark S., et al. Partial IGF affinity of circulating N- and C-terminal fragments of human insulin-like growth factor binding protein-4 (IGFBP-4) and the disulfide bonding pattern of the C-terminal IGFBP-4 domain. Biochemistry 2000, 39:5082-5088.
169. Ständker L., Wobst P., Mark S., et al. Isolation and characterization of circulating 13-kDa C-terminal fragments of human insulin-like growth factor binding protein-5. FEBS Lett 1998, 441:281-286.
170. Powell D.R., Liu F., Baker B.K., et al. Insulin-like growth factor-binding protein-6 levels are elevated in serum of children with chronic renal failure: a report of the Southwest Pediatric Nephrology Study Group. J Clin Endocrinol Metab 1997, 82:2978-2984.